Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study,a multicentre,randomized, double‐blind,active‐controlled,phase 3 trial期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study,a multicentre,randomized, double‐blind,active‐controlled,phase 3 trial

Authors:	Jingtao Dou MD PhD Jianhua Ma MD Jun Liu MD Changjiang Wang MD Eva Johnsson MD PhD Hui Yao MD June Zhao MD Changyu Pan MD

Affiliation:	1. Department of Endocrinology, The General Hospital of People's Liberation Army, Beijing, China;2. Department of Endocrinology, Nanjing First Hospital, Nanjing, China;3. Department of Endocrinology, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China;4. Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, China;5. Global Medicines Development, AstraZeneca, Gothenburg, M?lndal, Sweden;6. China Development Unit, AstraZeneca, Shanghai, China;7. AstraZeneca, Gaithersburg, Maryland

Abstract:

Keywords:	DPP‐4 inhibitor metformin oral antidiabetes drug saxagliptin type 2 diabetes